Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure.
Bioorg Med Chem. 2008 Feb 15;16(4):1992-2010. doi: 10.1016/j.bmc.2007.10.094. Epub 2007 Nov 4.
Bioorg Med Chem. 2008.
PMID: 18061460
Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17.
Pinto-Bazurco Mendieta MA, Negri M, Jagusch C, Hille UE, Müller-Vieira U, Schmidt D, Hansen K, Hartmann RW.
Pinto-Bazurco Mendieta MA, et al.
Bioorg Med Chem Lett. 2008 Jan 1;18(1):267-73. doi: 10.1016/j.bmcl.2007.10.079. Epub 2007 Oct 30.
Bioorg Med Chem Lett. 2008.
PMID: 18024111
Item in Clipboard
Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancer.
Pinto-Bazurco Mendieta MA, Negri M, Jagusch C, Müller-Vieira U, Lauterbach T, Hartmann RW.
Pinto-Bazurco Mendieta MA, et al.
J Med Chem. 2008 Aug 28;51(16):5009-18. doi: 10.1021/jm800355c. Epub 2008 Aug 2.
J Med Chem. 2008.
PMID: 18672868
Item in Clipboard
CYP17 inhibitors. Annulations of additional rings in methylene imidazole substituted biphenyls: synthesis, biological evaluation and molecular modelling.
Pinto-Bazurco Mendieta MA, Negri M, Hu Q, Hille UE, Jagusch C, Jahn-Hoffmann K, Müller-Vieira U, Schmidt D, Lauterbach T, Hartmann RW.
Pinto-Bazurco Mendieta MA, et al.
Arch Pharm (Weinheim). 2008 Oct;341(10):597-609. doi: 10.1002/ardp.200700251.
Arch Pharm (Weinheim). 2008.
PMID: 18720339
Item in Clipboard
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.
Pinto-Bazurco Mendieta MA, Hu Q, Engel M, Hartmann RW.
Pinto-Bazurco Mendieta MA, et al.
J Med Chem. 2013 Aug 8;56(15):6101-7. doi: 10.1021/jm400484p. Epub 2013 Jul 29.
J Med Chem. 2013.
PMID: 23859149
Item in Clipboard
Cite
Cite